MedTrace Logo

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

NCT00180466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 697

Last updated 2010-05-25

No results posted yet for this study

Summary

PROSPECT is a multi-center prospective registry of Acute Coronary Syndromes (ACS) patients with single or double vessel coronary artery disease. Approximately 700 patients with ACS will be enrolled into the study at sites in the United States and European Union.

Conditions

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Gregg Stone, MD · Columbia University

  • Patrick Serruys, MD, PhD · Thoraxcenter, Erasmus University, Rotterdam, The Netherlands

  • Bernard de Bruyne, MD · Cardiovascular Center, OLV Hospital, Aalst, Belgium

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2009-06-30
Completion
2009-07-31

Countries

  • United States
  • Belgium
  • Denmark
  • France
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180466 on ClinicalTrials.gov